| 2.8 |
22.5 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 2.5 |
12.7 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 2.1 |
6.4 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 2.0 |
6.0 |
GO:0071476 |
response to vitamin B1(GO:0010266) cellular hypotonic response(GO:0071476) |
| 1.8 |
5.5 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 1.7 |
5.0 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.6 |
8.0 |
GO:0044854 |
membrane raft assembly(GO:0001765) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 1.5 |
6.0 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 1.3 |
4.0 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
| 1.2 |
6.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 1.2 |
4.6 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 1.1 |
31.9 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.1 |
3.2 |
GO:0048627 |
myoblast development(GO:0048627) |
| 1.0 |
6.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.0 |
3.1 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.0 |
3.0 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 1.0 |
6.7 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.9 |
2.8 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.9 |
4.4 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 |
2.6 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.9 |
0.9 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.9 |
2.6 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.9 |
0.9 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.8 |
3.9 |
GO:0006789 |
bilirubin conjugation(GO:0006789) biphenyl metabolic process(GO:0018879) biphenyl catabolic process(GO:0070980) |
| 0.8 |
8.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.8 |
8.5 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.7 |
3.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.7 |
5.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.7 |
4.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.7 |
2.2 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.7 |
2.2 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.7 |
2.2 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.7 |
2.8 |
GO:0060209 |
estrus(GO:0060209) |
| 0.7 |
10.6 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.7 |
2.1 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.7 |
2.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.7 |
4.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.7 |
3.4 |
GO:0070884 |
calcineurin-NFAT signaling cascade(GO:0033173) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.7 |
2.7 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.7 |
15.2 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.7 |
2.0 |
GO:0060340 |
optic cup formation involved in camera-type eye development(GO:0003408) diencephalon morphogenesis(GO:0048852) positive regulation of type I interferon-mediated signaling pathway(GO:0060340) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.7 |
2.6 |
GO:0010716 |
regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
| 0.6 |
0.6 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.6 |
4.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.6 |
2.5 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.6 |
3.1 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) |
| 0.6 |
8.6 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.6 |
3.7 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.6 |
5.5 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.6 |
3.0 |
GO:0002885 |
positive regulation of hypersensitivity(GO:0002885) |
| 0.6 |
3.5 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.6 |
2.2 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.5 |
1.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.5 |
1.6 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.5 |
2.1 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.5 |
0.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.5 |
0.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.5 |
1.5 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.5 |
1.5 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.5 |
4.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
1.9 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.5 |
0.9 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.5 |
0.5 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.5 |
1.4 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.5 |
3.7 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.5 |
2.3 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.5 |
1.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.5 |
2.3 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.5 |
3.6 |
GO:1901998 |
antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
| 0.4 |
1.3 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.4 |
1.3 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.4 |
2.2 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 |
1.3 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.4 |
0.9 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.4 |
0.9 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.4 |
3.0 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.4 |
3.4 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.4 |
1.3 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 |
2.1 |
GO:0015827 |
tryptophan transport(GO:0015827) leucine import(GO:0060356) |
| 0.4 |
2.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.4 |
0.4 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.4 |
0.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.4 |
1.2 |
GO:0018243 |
protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
| 0.4 |
1.2 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.4 |
13.9 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.4 |
4.1 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.4 |
0.7 |
GO:0009635 |
response to herbicide(GO:0009635) |
| 0.4 |
0.7 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.4 |
0.4 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.4 |
1.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.4 |
4.3 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.4 |
0.7 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.4 |
1.8 |
GO:0010993 |
ubiquitin homeostasis(GO:0010992) regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.4 |
0.7 |
GO:0060761 |
negative regulation of response to cytokine stimulus(GO:0060761) |
| 0.4 |
1.4 |
GO:0009296 |
obsolete flagellum assembly(GO:0009296) |
| 0.4 |
1.1 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
0.7 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.3 |
2.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.3 |
1.4 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.3 |
1.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
1.0 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
| 0.3 |
4.4 |
GO:1901797 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
| 0.3 |
1.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.3 |
0.7 |
GO:0034201 |
response to oleic acid(GO:0034201) cellular response to oleic acid(GO:0071400) |
| 0.3 |
5.5 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.3 |
0.3 |
GO:0050653 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.3 |
1.6 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
0.3 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.3 |
1.0 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.3 |
0.6 |
GO:0070244 |
negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.3 |
1.0 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.3 |
0.9 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.3 |
0.9 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.3 |
0.9 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.3 |
0.3 |
GO:0018410 |
C-terminal protein amino acid modification(GO:0018410) |
| 0.3 |
0.9 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.3 |
2.1 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.3 |
1.5 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.3 |
0.6 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.3 |
0.3 |
GO:0002887 |
negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
| 0.3 |
0.9 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.3 |
2.1 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.3 |
0.9 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 |
4.3 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.3 |
0.3 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.3 |
0.3 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.3 |
0.3 |
GO:0010332 |
response to gamma radiation(GO:0010332) |
| 0.3 |
4.3 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.3 |
1.1 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.3 |
1.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
0.9 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.3 |
2.0 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.3 |
0.8 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.3 |
0.6 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 |
3.6 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
| 0.3 |
7.5 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.3 |
0.8 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.3 |
0.8 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.3 |
0.3 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.3 |
1.6 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 |
1.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 |
1.6 |
GO:0051563 |
smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.3 |
0.3 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.3 |
4.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
1.3 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.3 |
1.6 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.3 |
2.3 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.3 |
1.5 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.3 |
0.3 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.3 |
0.8 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.3 |
0.8 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.3 |
0.5 |
GO:0042311 |
vasodilation(GO:0042311) |
| 0.3 |
0.8 |
GO:0043526 |
obsolete neuroprotection(GO:0043526) |
| 0.2 |
1.5 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 |
1.2 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.2 |
2.0 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.2 |
0.5 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.2 |
2.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
0.7 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.2 |
1.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.2 |
2.0 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.2 |
1.5 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.2 |
0.5 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 |
1.7 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.2 |
1.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.9 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 |
0.5 |
GO:0097435 |
extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
| 0.2 |
0.9 |
GO:0006927 |
obsolete transformed cell apoptotic process(GO:0006927) |
| 0.2 |
0.2 |
GO:0032621 |
interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
| 0.2 |
1.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
4.5 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.2 |
0.2 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.2 |
0.5 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.7 |
GO:0060370 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 |
0.2 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
1.6 |
GO:0030041 |
actin filament polymerization(GO:0030041) |
| 0.2 |
0.2 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.2 |
0.9 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
4.3 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
1.4 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.2 |
0.9 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.2 |
0.7 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 |
0.7 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.2 |
0.2 |
GO:0044818 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) mitotic G2/M transition checkpoint(GO:0044818) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
| 0.2 |
1.7 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
6.7 |
GO:0006693 |
prostaglandin metabolic process(GO:0006693) |
| 0.2 |
0.4 |
GO:0032527 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.2 |
0.9 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.2 |
0.6 |
GO:0046639 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.2 |
0.4 |
GO:0071801 |
podosome assembly(GO:0071800) regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
0.6 |
GO:0050678 |
regulation of epithelial cell proliferation(GO:0050678) |
| 0.2 |
0.4 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 |
1.1 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.2 |
0.6 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 |
0.4 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
| 0.2 |
4.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
0.8 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.2 |
1.0 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.2 |
0.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 |
1.7 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
1.0 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.2 |
0.4 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 |
4.3 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.2 |
0.8 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.2 |
0.4 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.2 |
0.4 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.2 |
4.4 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.2 |
0.8 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.2 |
0.4 |
GO:0090286 |
nuclear matrix organization(GO:0043578) cytoskeletal anchoring at nuclear membrane(GO:0090286) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.2 |
1.0 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
0.6 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) |
| 0.2 |
0.6 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.2 |
0.6 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.2 |
0.8 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.2 |
1.0 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 |
0.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
0.8 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.2 |
0.2 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.2 |
3.6 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.2 |
5.7 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.2 |
11.9 |
GO:0034332 |
adherens junction organization(GO:0034332) |
| 0.2 |
0.9 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
| 0.2 |
0.2 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.2 |
2.0 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.2 |
0.6 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.2 |
0.7 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.2 |
0.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
1.5 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.2 |
0.4 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.2 |
0.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
14.0 |
GO:0090132 |
epithelial cell migration(GO:0010631) tissue migration(GO:0090130) epithelium migration(GO:0090132) |
| 0.2 |
1.8 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 |
0.5 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.2 |
0.7 |
GO:0060347 |
heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
| 0.2 |
3.5 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.2 |
0.9 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.2 |
0.7 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.2 |
2.1 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.2 |
1.9 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.2 |
3.8 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.2 |
0.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.2 |
0.5 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 |
1.4 |
GO:0019614 |
phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.2 |
1.7 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.2 |
1.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
0.5 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.2 |
0.8 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
1.2 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.2 |
0.2 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.2 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.7 |
GO:0036336 |
dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
| 0.2 |
1.2 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.2 |
0.3 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.2 |
0.2 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.2 |
0.5 |
GO:0002237 |
response to molecule of bacterial origin(GO:0002237) |
| 0.2 |
0.8 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
| 0.2 |
10.1 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.2 |
2.9 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
1.0 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.2 |
0.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.2 |
0.5 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
0.3 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.2 |
0.6 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 |
1.4 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.2 |
0.5 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.2 |
0.5 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
0.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
1.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.2 |
1.1 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.3 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.2 |
0.2 |
GO:0031034 |
skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
1.8 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
1.6 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 |
0.4 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.6 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.1 |
0.3 |
GO:0060688 |
regulation of morphogenesis of a branching structure(GO:0060688) |
| 0.1 |
0.9 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.1 |
0.1 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.1 |
0.1 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.9 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.4 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
1.7 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.9 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.1 |
9.6 |
GO:0008544 |
epidermis development(GO:0008544) |
| 0.1 |
1.0 |
GO:0050773 |
regulation of dendrite development(GO:0050773) |
| 0.1 |
0.7 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.1 |
0.3 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.4 |
GO:0035269 |
protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
| 0.1 |
0.3 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
1.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.1 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
| 0.1 |
1.0 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
0.8 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.4 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.4 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
1.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.3 |
GO:0035120 |
post-embryonic appendage morphogenesis(GO:0035120) |
| 0.1 |
0.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.4 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.8 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
1.7 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.8 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.1 |
0.7 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
1.6 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.1 |
0.7 |
GO:0030850 |
prostate gland development(GO:0030850) |
| 0.1 |
0.4 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
1.3 |
GO:0003407 |
neural retina development(GO:0003407) |
| 0.1 |
1.4 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.3 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
0.9 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) |
| 0.1 |
0.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.5 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.1 |
0.9 |
GO:0042559 |
folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 |
0.5 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 |
0.5 |
GO:0002220 |
innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.1 |
0.9 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
8.0 |
GO:0030832 |
regulation of actin filament length(GO:0030832) |
| 0.1 |
0.9 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.5 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.4 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
1.2 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.5 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
0.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
1.5 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.5 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.2 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
| 0.1 |
1.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
0.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
0.2 |
GO:0034635 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.1 |
0.4 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.1 |
0.3 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) |
| 0.1 |
12.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.8 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.1 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
1.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.8 |
GO:0034465 |
cellular potassium ion homeostasis(GO:0030007) response to carbon monoxide(GO:0034465) negative regulation of cell volume(GO:0045794) |
| 0.1 |
0.3 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
0.2 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.3 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.1 |
1.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
1.0 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 |
0.2 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.1 |
0.3 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
0.4 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.1 |
0.2 |
GO:0060253 |
negative regulation of glial cell proliferation(GO:0060253) |
| 0.1 |
0.1 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.1 |
0.9 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
0.3 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.1 |
1.6 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 |
1.1 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
2.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
1.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.5 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
1.1 |
GO:0006091 |
generation of precursor metabolites and energy(GO:0006091) |
| 0.1 |
1.4 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.2 |
GO:0009820 |
alkaloid metabolic process(GO:0009820) |
| 0.1 |
1.4 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.2 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.1 |
4.5 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 |
0.2 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
4.4 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.1 |
0.5 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 |
1.0 |
GO:0010092 |
specification of organ identity(GO:0010092) |
| 0.1 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 |
1.9 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
1.3 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 |
2.5 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.1 |
0.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
7.1 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
6.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.6 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.3 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) spermine metabolic process(GO:0008215) |
| 0.1 |
0.1 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.1 |
0.6 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
| 0.1 |
0.2 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.1 |
3.6 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.8 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.1 |
0.2 |
GO:0060571 |
morphogenesis of an epithelial fold(GO:0060571) |
| 0.1 |
0.1 |
GO:0043501 |
skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) skeletal muscle adaptation(GO:0043501) |
| 0.1 |
0.5 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.1 |
GO:0010460 |
positive regulation of heart rate(GO:0010460) |
| 0.1 |
4.0 |
GO:0043588 |
skin development(GO:0043588) |
| 0.1 |
8.1 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
| 0.1 |
0.6 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.1 |
0.4 |
GO:1903008 |
organelle disassembly(GO:1903008) |
| 0.1 |
0.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
0.5 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.1 |
0.3 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
0.5 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.1 |
0.5 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
1.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.5 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 |
2.2 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.1 |
0.4 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.1 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.3 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.1 |
0.4 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
1.7 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 |
2.4 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.2 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.1 |
GO:0044275 |
cellular carbohydrate catabolic process(GO:0044275) |
| 0.1 |
5.8 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.1 |
0.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.2 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.1 |
0.2 |
GO:0045415 |
negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 |
0.3 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
0.5 |
GO:0099515 |
nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.1 |
1.1 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.2 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.2 |
GO:0050965 |
detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.4 |
GO:0090280 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) positive regulation of calcium ion import(GO:0090280) |
| 0.1 |
0.2 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.1 |
0.2 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
1.2 |
GO:0072595 |
maintenance of protein location in nucleus(GO:0051457) maintenance of protein localization in organelle(GO:0072595) |
| 0.1 |
2.0 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.1 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.1 |
0.5 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 |
0.2 |
GO:0046368 |
GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.1 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.2 |
GO:0008049 |
male courtship behavior(GO:0008049) |
| 0.1 |
1.2 |
GO:0070328 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.4 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.1 |
0.2 |
GO:0055007 |
cardiac muscle cell differentiation(GO:0055007) |
| 0.1 |
0.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.2 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.1 |
0.3 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.4 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
0.5 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.1 |
0.2 |
GO:0045916 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.1 |
5.5 |
GO:0007565 |
female pregnancy(GO:0007565) |
| 0.1 |
0.3 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.7 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.5 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
| 0.1 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.2 |
GO:0043441 |
acetoacetic acid biosynthetic process(GO:0043441) |
| 0.1 |
5.3 |
GO:0052547 |
regulation of peptidase activity(GO:0052547) |
| 0.1 |
0.3 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
1.8 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.1 |
0.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.1 |
0.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.1 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 |
0.3 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.3 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.1 |
1.2 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.1 |
GO:0010661 |
positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
1.1 |
GO:1901661 |
quinone metabolic process(GO:1901661) |
| 0.1 |
0.1 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.1 |
0.1 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.3 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.1 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.3 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
9.8 |
GO:0071466 |
xenobiotic metabolic process(GO:0006805) response to xenobiotic stimulus(GO:0009410) cellular response to xenobiotic stimulus(GO:0071466) |
| 0.1 |
1.4 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.1 |
0.1 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.1 |
0.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.1 |
GO:0072283 |
mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) mesenchymal to epithelial transition(GO:0060231) renal vesicle morphogenesis(GO:0072077) renal vesicle development(GO:0072087) metanephric renal vesicle morphogenesis(GO:0072283) |
| 0.1 |
0.5 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.2 |
GO:1903018 |
regulation of glycoprotein metabolic process(GO:1903018) |
| 0.1 |
3.6 |
GO:0017148 |
negative regulation of translation(GO:0017148) |
| 0.1 |
0.3 |
GO:0050772 |
positive regulation of cell morphogenesis involved in differentiation(GO:0010770) positive regulation of axonogenesis(GO:0050772) |
| 0.1 |
0.4 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.3 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.1 |
0.1 |
GO:0051957 |
positive regulation of amino acid transport(GO:0051957) |
| 0.1 |
0.8 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.1 |
0.3 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
2.5 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.1 |
11.8 |
GO:0006936 |
muscle contraction(GO:0006936) |
| 0.1 |
3.3 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.1 |
0.1 |
GO:0042506 |
tyrosine phosphorylation of Stat5 protein(GO:0042506) |
| 0.1 |
0.2 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.1 |
3.1 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.1 |
0.6 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.1 |
0.2 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
1.1 |
GO:0007613 |
memory(GO:0007613) |
| 0.1 |
1.7 |
GO:0045768 |
obsolete positive regulation of anti-apoptosis(GO:0045768) |
| 0.1 |
0.6 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.1 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
7.3 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.1 |
0.6 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
0.2 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.4 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 |
0.2 |
GO:0031641 |
regulation of myelination(GO:0031641) |
| 0.1 |
0.9 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.1 |
GO:0042510 |
regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
| 0.1 |
1.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
1.2 |
GO:0070988 |
demethylation(GO:0070988) |
| 0.1 |
0.6 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.9 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
0.1 |
GO:0007033 |
vacuole organization(GO:0007033) |
| 0.1 |
0.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
| 0.1 |
0.1 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 |
0.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.3 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.1 |
0.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.2 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
0.9 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.1 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.7 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.1 |
0.3 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
2.3 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.7 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
1.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
1.0 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.4 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
| 0.1 |
1.9 |
GO:0033572 |
ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.1 |
0.1 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.1 |
0.1 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.1 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.6 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.1 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.2 |
GO:0071599 |
otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
| 0.0 |
0.9 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.0 |
0.7 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.2 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
0.1 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 |
0.0 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.1 |
GO:0022028 |
olfactory bulb interneuron differentiation(GO:0021889) olfactory bulb interneuron development(GO:0021891) tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.0 |
0.4 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.0 |
0.6 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.2 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
| 0.0 |
0.0 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.6 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.1 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.2 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.0 |
0.1 |
GO:0021570 |
rhombomere 4 development(GO:0021570) |
| 0.0 |
0.0 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.0 |
0.4 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
0.0 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.0 |
GO:0043558 |
regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
| 0.0 |
0.2 |
GO:0048593 |
camera-type eye morphogenesis(GO:0048593) |
| 0.0 |
0.5 |
GO:0001707 |
mesoderm formation(GO:0001707) |
| 0.0 |
0.1 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.0 |
0.6 |
GO:0043149 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 |
0.2 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.0 |
0.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.0 |
0.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.2 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.4 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 |
0.1 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.0 |
0.3 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.1 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
1.9 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.1 |
GO:2000181 |
negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 |
0.1 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.0 |
0.2 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
0.1 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.0 |
2.4 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.3 |
GO:0030518 |
intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.0 |
0.7 |
GO:0006029 |
proteoglycan metabolic process(GO:0006029) |
| 0.0 |
0.1 |
GO:0018377 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.0 |
0.1 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.0 |
0.1 |
GO:0030858 |
positive regulation of epithelial cell differentiation(GO:0030858) |
| 0.0 |
0.2 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.0 |
0.0 |
GO:0032612 |
interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
| 0.0 |
2.5 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.2 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.1 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 |
0.0 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.2 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.2 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 |
0.1 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.3 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.0 |
GO:0046717 |
acid secretion(GO:0046717) |
| 0.0 |
0.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.0 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 |
0.3 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
| 0.0 |
0.5 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.2 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.0 |
0.0 |
GO:0002331 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.0 |
0.3 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.0 |
0.0 |
GO:0009953 |
dorsal/ventral pattern formation(GO:0009953) |
| 0.0 |
0.0 |
GO:0001993 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
| 0.0 |
0.0 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.1 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.1 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.3 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.0 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.2 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
2.2 |
GO:0006814 |
sodium ion transport(GO:0006814) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.0 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.0 |
0.3 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
1.9 |
GO:0034329 |
cell junction assembly(GO:0034329) |
| 0.0 |
0.1 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.0 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.3 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.7 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.1 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.1 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.1 |
GO:0007350 |
blastoderm segmentation(GO:0007350) |
| 0.0 |
1.1 |
GO:0006914 |
autophagy(GO:0006914) |
| 0.0 |
0.1 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.0 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.2 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
1.1 |
GO:0016197 |
endosomal transport(GO:0016197) |
| 0.0 |
0.0 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.4 |
GO:0045727 |
positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.7 |
GO:0007623 |
circadian rhythm(GO:0007623) |
| 0.0 |
0.1 |
GO:0045814 |
negative regulation of gene expression, epigenetic(GO:0045814) |
| 0.0 |
0.3 |
GO:0051875 |
pigment granule localization(GO:0051875) |
| 0.0 |
0.1 |
GO:0043406 |
positive regulation of MAP kinase activity(GO:0043406) |
| 0.0 |
0.7 |
GO:0007173 |
epidermal growth factor receptor signaling pathway(GO:0007173) ERBB signaling pathway(GO:0038127) |
| 0.0 |
1.0 |
GO:0006986 |
response to unfolded protein(GO:0006986) |
| 0.0 |
0.0 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.0 |
0.2 |
GO:0009218 |
pyrimidine ribonucleotide metabolic process(GO:0009218) |
| 0.0 |
0.1 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.0 |
GO:0060014 |
granulosa cell differentiation(GO:0060014) |
| 0.0 |
0.0 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 |
0.1 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.2 |
GO:1902603 |
carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.0 |
0.2 |
GO:0030819 |
positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 |
0.0 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.0 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.0 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 |
0.1 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.1 |
GO:0042439 |
ethanolamine-containing compound metabolic process(GO:0042439) phosphatidylcholine metabolic process(GO:0046470) |
| 0.0 |
0.7 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
0.1 |
GO:0032094 |
response to food(GO:0032094) |
| 0.0 |
0.3 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:0051209 |
release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
| 0.0 |
0.8 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.1 |
GO:0018101 |
citrulline metabolic process(GO:0000052) protein citrullination(GO:0018101) |
| 0.0 |
0.3 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.0 |
0.1 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.0 |
0.0 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.1 |
GO:0050931 |
melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.0 |
GO:0002385 |
innate immune response in mucosa(GO:0002227) organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.0 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.1 |
GO:0007409 |
axonogenesis(GO:0007409) |
| 0.0 |
0.2 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.0 |
0.0 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.1 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 |
0.0 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.0 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.1 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.0 |
0.0 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.1 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.0 |
0.0 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.0 |
0.1 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.0 |
0.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.1 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.1 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.0 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.0 |
0.1 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.1 |
GO:0051899 |
membrane depolarization(GO:0051899) |
| 0.0 |
0.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
